Home » Topics » Regulatory » Patents

Patents
RSS

New agents for treating neurological disorders reported in recent patents

Nov. 20, 2006

New therapeutic agents for schizophrenia, anxiety, etc. disclosed in recent patents

Nov. 20, 2006

Recent Protemix and Dainippon Sumitomo patents describe new antidiabetic agents

Nov. 20, 2006

Patents reveal novel agents for ulcer, inflammatory bowel disease, etc.

Nov. 17, 2006

Agents for atherosclerosis, pulmonary hypertension patented

Nov. 17, 2006

Recent patents disclose novel antiinfective agents

Nov. 17, 2006

Recent patents report novel analgesic agents

Nov. 16, 2006

Recent patents impart new therapeutic agents for cancer

Nov. 16, 2006

New agent for glaucoma disclosed in recent Johns Hopkins University patent

Nov. 15, 2006

Recent patents disclose new therapeutic agents for anxiety, depression, etc

Nov. 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...